Evidence that resistance to nilotinib may be due to BCR-ABL, Pgp, or Src kinase overexpression.
- DOI
- 10.1158/0008-5472.can-08-1008
- Published
- 2008 Dec 1
- Container
- Cancer research
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1158/0008-5472.can-08-1008,
title = {Evidence that resistance to nilotinib may be due to BCR-ABL, Pgp, or Src kinase overexpression.},
author = {Mahon FX and Hayette S and Lagarde V and Belloc F and Turcq B and Nicolini F and Belanger C and Manley PW and Leroy C and Etienne G and Roche S and Pasquet JM},
year = {2008},
journal = {Cancer research},
doi = {10.1158/0008-5472.can-08-1008},
url = {https://doi.org/10.1158/0008-5472.can-08-1008}
}RIS
TY - JOUR TI - Evidence that resistance to nilotinib may be due to BCR-ABL, Pgp, or Src kinase overexpression. AU - Mahon FX AU - Hayette S AU - Lagarde V AU - Belloc F AU - Turcq B AU - Nicolini F AU - Belanger C AU - Manley PW AU - Leroy C AU - Etienne G AU - Roche S AU - Pasquet JM PY - 2008 JO - Cancer research DO - 10.1158/0008-5472.can-08-1008 UR - https://doi.org/10.1158/0008-5472.can-08-1008 ER -
APA
FX, M., S, H., V, L., F, B., B, T., F, N., C, B., PW, M., C, L., G, E., S, R., & JM, P. (2008). Evidence that resistance to nilotinib may be due to BCR-ABL, Pgp, or Src kinase overexpression.. Cancer research. https://doi.org/10.1158/0008-5472.can-08-1008